Moneycontrol PRO

Concord Drugs Standalone March 2022 Net Sales at Rs 15.46 crore, up 85.29% Y-o-Y

May 31, 2022 / 02:28 PM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Reported Standalone quarterly numbers for Concord Drugs are:

Net Sales at Rs 15.46 crore in March 2022 up 85.29% from Rs. 8.35 crore in March 2021.

Quarterly Net Profit at Rs. 0.03 crore in March 2022 down 91.87% from Rs. 0.34 crore in March 2021.

EBITDA stands at Rs. 0.68 crore in March 2022 down 9.33% from Rs. 0.75 crore in March 2021.

Concord Drugs EPS has decreased to Rs. 0.03 in March 2022 from Rs. 0.38 in March 2021.

Close

Concord Drugs shares closed at 27.10 on May 30, 2022 (BSE)

Concord Drugs
Standalone Quarterly Resultsin Rs. Cr.
Mar'22Dec'21Mar'21
Net Sales/Income from operations15.4613.448.35
Other Operating Income------
Total Income From Operations15.4613.448.35
EXPENDITURE
Consumption of Raw Materials10.6610.665.53
Purchase of Traded Goods------
Increase/Decrease in Stocks-1.930.160.43
Power & Fuel------
Employees Cost1.601.200.92
Depreciation0.370.300.33
Excise Duty------
Admin. And Selling Expenses------
R & D Expenses------
Provisions And Contingencies------
Exp. Capitalised------
Other Expenses4.480.390.74
P/L Before Other Inc. , Int., Excpt. Items & Tax0.290.730.39
Other Income0.020.030.02
P/L Before Int., Excpt. Items & Tax0.310.760.42
Interest0.230.180.27
P/L Before Exceptional Items & Tax0.080.580.14
Exceptional Items----0.24
P/L Before Tax0.080.580.38
Tax0.050.160.05
P/L After Tax from Ordinary Activities0.030.420.34
Prior Year Adjustments------
Extra Ordinary Items------
Net Profit/(Loss) For the Period0.030.420.34
Equity Share Capital8.748.748.74
Reserves Excluding Revaluation Reserves------
Equity Dividend Rate (%)------
EPS Before Extra Ordinary
Basic EPS0.030.480.38
Diluted EPS0.030.480.38
EPS After Extra Ordinary
Basic EPS0.030.480.38
Diluted EPS0.030.480.38
Public Share Holding
No Of Shares (Crores)------
Share Holding (%)------
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores)------
- Per. of shares (as a % of the total sh. of prom. and promoter group)------
- Per. of shares (as a % of the total Share Cap. of the company)------
b) Non-encumbered
- Number of shares (Crores)------
- Per. of shares (as a % of the total sh. of prom. and promoter group)------
- Per. of shares (as a % of the total Share Cap. of the company)------
Source : Dion Global Solutions Limited

first published: May 31, 2022 02:17 pm
Sections
ISO 27001 - BSI Assurance Mark